Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux.

Masaany M, Marina MB, Sharifa Ezat WP, Sani A.

J Laryngol Otol. 2011 May;125(5):502-8. doi: 10.1017/S0022215111000120. Epub 2011 Feb 28.

PMID:
21356141
2.

Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy?

Vailati C, Mazzoleni G, Bondi S, Bussi M, Testoni PA, Passaretti S.

J Voice. 2013 Jan;27(1):84-9. doi: 10.1016/j.jvoice.2012.08.006. Epub 2012 Nov 15.

PMID:
23159026
3.

Reflux symptom index and reflux finding score in otolaryngologic practice.

Habermann W, Schmid C, Neumann K, Devaney T, Hammer HF.

J Voice. 2012 May;26(3):e123-7. doi: 10.1016/j.jvoice.2011.02.004. Epub 2011 Apr 7.

PMID:
21477986
4.

Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome.

Lien HC, Wang CC, Liang WM, Sung FC, Hsu JY, Yeh HZ, Chong K, Chang CS.

Laryngoscope. 2013 Jun;123(6):1483-9. doi: 10.1002/lary.23780. Epub 2013 Apr 3.

PMID:
23553459
5.

Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.

Siupsinskiene N, Adamonis K, Toohill RJ, Sereika R.

J Laryngol Otol. 2008 Nov;122(11):1206-12. doi: 10.1017/S0022215108001898. Epub 2008 Mar 11.

PMID:
18331659
6.

LPR: how different diagnostic tools shape the outcomes of treatment.

Wan Y, Yan Y, Ma F, Wang L, Lu P, Maytag A, Jiang JJ.

J Voice. 2014 May;28(3):362-8. doi: 10.1016/j.jvoice.2013.12.004. Epub 2014 Feb 1.

PMID:
24491501
7.

The value of routine pH monitoring in the diagnosis and treatment of laryngopharyngeal reflux.

Friedman M, Hamilton C, Samuelson CG, Kelley K, Taylor R, Darling R, Taylor D, Fisher M, Maley A.

Otolaryngol Head Neck Surg. 2012 Jun;146(6):952-8. doi: 10.1177/0194599812436952. Epub 2012 Feb 2.

PMID:
22301104
8.

Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.

Xiao YL, Peng S, Tao J, Wang AJ, Lin JK, Hu PJ, Chen MH.

Am J Gastroenterol. 2010 Dec;105(12):2626-31. doi: 10.1038/ajg.2010.351. Epub 2010 Sep 7.

PMID:
20823838
9.

[Diagnosis and treatment of laryngopharyngeal reflux disease].

Zhao R, Liu H.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Aug;25(15):690-1. Chinese.

PMID:
22010339
10.

Clinical features and diagnostic reliability in paediatric laryngopharyngeal reflux.

Baudoin T, Kosec A, Cor IS, Zaja O.

Int J Pediatr Otorhinolaryngol. 2014 Jul;78(7):1101-6. doi: 10.1016/j.ijporl.2014.04.024. Epub 2014 Apr 24.

PMID:
24833166
11.

Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population.

Mohd H, Qua CS, Wong CH, Azman W, Goh KL.

J Gastroenterol Hepatol. 2009 Feb;24(2):288-93. doi: 10.1111/j.1440-1746.2008.05702.x. Epub 2008 Nov 26.

PMID:
19054255
12.

Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.

Lee YC, Lee JS, Kim SW, Kwon KH, Eun YG.

JAMA Otolaryngol Head Neck Surg. 2013 Dec;139(12):1291-5. doi: 10.1001/jamaoto.2013.5556.

PMID:
24201320
13.

The effect of anti-reflux treatment on subjective voice measurements of patients with laryngopharyngeal reflux.

Beech TJ, Campbell G, McDermott AL, Batch AJ.

J Laryngol Otol. 2013 Jun;127(6):590-4. doi: 10.1017/S0022215113000832. Epub 2013 May 3.

PMID:
23642303
14.

Efficacy of super high dose proton pump inhibitor administration in refractory laryngopharyngeal reflux: a pilot study.

Portnoy JE, Gregory ND, Cerulli CE, Hawkshaw MJ, Lurie D, Katz PO, Sataloff RT.

J Voice. 2014 May;28(3):369-77. doi: 10.1016/j.jvoice.2013.10.020. Epub 2014 Feb 1.

PMID:
24495427
15.

Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.

Kim JH, Sinn DH, Son HJ, Kim JJ, Rhee JC, Rhee PL.

J Gastroenterol Hepatol. 2009 Sep;24(9):1504-9. doi: 10.1111/j.1440-1746.2009.05859.x.

PMID:
19467139
16.

A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors.

Dulery C, Lechot A, Roman S, Bastier PL, Stoll D, de Gabory L, Zerbib F.

Neurogastroenterol Motil. 2017 Jan;29(1). doi: 10.1111/nmo.12909. Epub 2016 Jul 18.

PMID:
27424517
17.

Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.

Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E.

Am J Gastroenterol. 2006 Sep;101(9):1972-8; quiz 2169.

PMID:
16968502
18.

Predictors of acid suppression success in patients with chronic laryngitis.

Wang AJ, Liang MJ, Jiang AY, Lin JK, Xiao YL, Peng S, Chen J, Wen WP, Chen MH.

Neurogastroenterol Motil. 2012 May;24(5):432-7, e210. doi: 10.1111/j.1365-2982.2011.01873.x. Epub 2012 Jan 25.

PMID:
22276941
19.

[Preliminary application of Dx-pH monitoring system in laryngopharyngeal reflux disease].

Han HL, Zhao JH, Zhang YL, Wang M, Wang HF, Cheng JN, Feng Y, Luo KQ, Lyu QP.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Sep 7;51(9):666-670. doi: 10.3760/cma.j.issn.1673-0860.2016.09.006. Chinese.

PMID:
27666704
20.

Linguistic Adaptation, Reliability, Validation, and Responsivity of the Chinese Version of Reflux Symptom Index.

Li J, Zhang L, Zhang C, Cheng JY, Li J, Jeff Cheng CF.

J Voice. 2016 Jan;30(1):104-8. doi: 10.1016/j.jvoice.2013.12.006. Epub 2015 Aug 17.

PMID:
26292798

Supplemental Content

Support Center